🟢 10x Genomics is trading 9.49% up today on positive melanoma vaccine results

10x Genomics is trading 9.49% up now at $60.07 as biotechnology shares rally on positive late-stage melanoma vaccine results from Moderna and Merck.

• The industry-wide catalyst is lifting sentiment toward biotech innovation and drug-development platforms, providing the clearest explanation for the early-session move.
• No new company-specific announcement, earnings release, or direct 10x Genomics catalyst was identified for August 19, 2026.